The IFPB is delighted to announce the following plenary speakers for the International Review of Psychosis & Bipolarity 2016
Director of the Central Institute of Mental Health, as well as the Medical Director of the Department of Psychiatry and Psychotherapy at the Institute, based in Mannheim, Germany and Professor and Chairman of Psychiatry and Psychotherapy at the University of Heidelberg in Heidelberg, Germany.
Prof. Dr. Meyer-Lindenberg is Director of the Central Institute of Mental Health, as well as the Medical Director of the Department of Psychiatry and Psychotherapy at the Institute, based in Mannheim, Germany and Professor and Chairman of Psychiatry and Psychotherapy at the University of Heidelberg in Heidelberg, Germany, and he is board certified in psychiatry, psychotherapy, and neurology. Before coming to Mannheim in 2007, he spent ten years as a scientist at the National Institutes of Mental Health, Bethesda, USA.
Prof. Dr. Meyer-Lindenberg is the author of more than 200 peer-reviewed articles in journals such as Nature, Science, Nature Neuroscience, Nature Medicine, Nature Reviews Neuroscience, Neuron, PNAS, and others. He is on the editorial board of a number of journals, such as Biological Psychiatry, Schizophrenia Bulletin, European Neuropsychopharmacology, Psychiatry Research: Neuroimaging, and Neuroimage.
His research interests focus on the development of novel treatments for severe psychiatric disorders, especially schizophrenia, through an application of multimodal neuroimaging, genetics and enviromics to characterize brain circuits underlying the risk for mental illness and cognitive dysfunction
In recognition of his research, Prof. Dr. Meyer-Lindenberg has received awards throughout his career, including the Joel Elkes International Award for Clinical Research from the American College of Neuropsychopharmacology (2006), the A.E. Bennett Award of the Society for Biological Psychiatry (2007), Kurt Schneider Scientific Award (2010), the Hans-Jörg Weitbrecht-Preis für Klinische Neurowissenschaften (2011), and the ECNP Neuropsychopharmacology Award, 2012.